Improving Risk Stratification of Emergency Department Patients With Acute Heart Failure

NCT ID: NCT06065761

Last Updated: 2024-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

17459 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary goal is to build and test a previously developed and validated risk model and clinical decision support tool embedded within the electronic health record to improve risk stratification of emergency department (ED) patients with acute heart failure (AHF).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study team will build an electronic health record-embedded clinical decision support tool using a recently developed risk prediction model that curates patient-specific data in real-time, accurately estimates short-term patient risk, and presents tailored clinical recommendations. This will be a regional implementation study in which the tool is turned on at 21 emergency departments (ED) across Kaiser Permanente Northern California (KPNC). The study team will validate risk predictions and study key clinical outcomes as part of this trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comprehensive ED heart failure management tool

The investigators plan a regional implementation of an electronic health record-based heart failure decision support tool across 21 EDs of Kaiser Permanente Northern California (KPNC).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥18y) KPNC members treated in the ED for presumed acute heart failure

Exclusion Criteria

* Children (\<18y).
* Patients who left against medical advice or eloped prior to ED physician evaluation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaiser Permanente Antioch Emergency Department

Antioch, California, United States

Site Status

Kaiser Permanente Fremont Emergency Department

Fremont, California, United States

Site Status

Kaiser Permanente Fresno Medical Center

Fresno, California, United States

Site Status

Kaiser Permanente Manteca Medical Center

Manteca, California, United States

Site Status

Kaiser Permanente Modesto Medical Center

Modesto, California, United States

Site Status

Kaiser Permanente Oakland Emergency Department

Oakland, California, United States

Site Status

Kaiser Permanente Redwood City Emergency Department

Redwood City, California, United States

Site Status

Kaiser Permanente Richmond Emergency Department

Richmond, California, United States

Site Status

Kaiser Permanente Roseville Emergency Department

Roseville, California, United States

Site Status

Kaiser Permanente South Sacramento Emergency Department

Sacramento, California, United States

Site Status

Kaiser Permanente Sacramento Emergency Department

Sacramento, California, United States

Site Status

Kaiser Permanente San Francisco Emergency Department

San Francisco, California, United States

Site Status

Kaiser Permanente San Jose Emergency Department

San Jose, California, United States

Site Status

Kaiser Permanente San Leandro Emergency Department

San Leandro, California, United States

Site Status

Kaiser Permanente San Rafael Emergency Department

San Rafael, California, United States

Site Status

Kaiser Permanente Santa Clara Emergency Department

Santa Clara, California, United States

Site Status

Kaiser Permanente Santa Rosa Emergency Department

Santa Rosa, California, United States

Site Status

Kaiser Permanente South San Francisco Emergency Department

South San Francisco, California, United States

Site Status

Kaiser Permanente Vacaville Medical Center

Vacaville, California, United States

Site Status

Kaiser Permanente Vallejo Medical Center

Vallejo, California, United States

Site Status

Kaiser Permanente Walnut Creek Medical Center

Walnut Creek, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dana R Sax, MD, MPH

Role: CONTACT

510-891-3400

Adina S Rauchwerger, MPH

Role: CONTACT

510-891-3400

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dana R Sax, MD, MPH

Role: primary

Dana R Sax, MD, MPH

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1719171

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.